The lung is the first site of distant metastases in up to 25% of the patients with HER2-positive breast cancer, and lung metastases are more common in the patient population with HER2-positive breast cancer compared to the other main biological subgroups of breast cancer [7, 8]. This evidence concerns the gene ERBB2 and breast carcinoma.